The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
Delineation of the genomic complexities of malignant pleural mesothelioma (MPM) has lagged behind other malignancies. Zhang et al. meaningfully add to our understanding of MPM, and their findings emphasize the need to combine drug development efforts with appropriate predictive biomarkers.
Enregistré dans:
Auteur principal: | Marjorie G. Zauderer |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8049a635b45f44a6ac1f11106fa5999b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cytomegalovirus infection in malignant pleural mesothelioma.
par: DeVon Hunter-Schlichting, et autres
Publié: (2021) -
Modern management of malignant pleural mesothelioma
par: Patel SC, et autres
Publié: (2016) -
Clinical staging of malignant pleural mesothelioma: current perspectives
par: Bonomi M, et autres
Publié: (2017) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
par: Sara Ricciardi, et autres
Publié: (2021) -
CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma
par: Masayuki Watanabe, et autres
Publié: (2021)